Comprehensive Family Immunization

PAHO’s Immunization Unit welcomes all health workers but especially the managers of the immunization program and the managers with responsibility for cold chain and supply chain operations to our website. Your website is dedicated to provide managers and readers information and technical guidelines for supporting you in achieving outstanding performance of the operations in the areas of cold chain and supply chain. The development and expansion of the vaccine cold chain have been based on the following goals established since 1979: Training; Information systems; Accessing new hard and soft technologies; Evaluating the operations of the CC and SC; and Budgeting and Planning.

Today’s immunization cold chain and supply chain operations have been one of the key elements in expanding the provision of daily immunization services and allowing more people to be protected from vaccine preventable diseases. When the PAHO Immunization Unit was established in 1977, both PAHO and national program staff understood that the immunization cold chain was the dorsal column of the program.

homepage peopleworking

Keeping vaccines potent

To assure that vaccines provided the expected benefits when a patient received an immunization, scientist, epidemiologist and health staff understood that each dose of vaccine administered had to be potent for protecting the recipient against the targeted disease(s). To achieve this objective efforts, the Immunization Unit, in PAHO, focused five pillars. The first pillar is recommending that countries use good quality refrigeration equipment which complies with WHO standards.

"Get vaccinated, Prevent diseases"

Granada-Agatha Telesford Mitchell
Agatha Telesford Mitchell
St. George's Health Centre

Recent Immunization News

WHO outlines steps to save 7 million lives from cancer

The World Health Organization (WHO) today spells out the need to step up cancer services in low and middle-income countries. WHO warns that, if current trends continue, the world will see a 60% increase in cancer cases over the next two decades. The greatest increase (an estimated 81%) in new cases will occur in low- and middle-income countries, where survival rates are currently lowest.